Crossref
Optimizing Anticoagulation in Atrial Fibrillation: The Role of Clinical Pharmacists in Canadian Practice
International Journal of Clinical Pharmacy and Medicine · 30.09.2026 · 1 (4)
DOI: 10.68760/ijcpm.2026.01 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Pharmacy and Medicine, online erschienen am 30.09.2026. Verfasst von Mohamed Abdellatif.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Abdellatif, M. (2026). Optimizing Anticoagulation in Atrial Fibrillation: The Role of Clinical Pharmacists in Canadian Practice. International Journal of Clinical Pharmacy and Medicine, 1(4). https://doi.org/10.68760/ijcpm.2026.01
Vancouver
Abdellatif M. Optimizing Anticoagulation in Atrial Fibrillation: The Role of Clinical Pharmacists in Canadian Practice. International Journal of Clinical Pharmacy and Medicine. 2026;1(4). doi:10.68760/ijcpm.2026.01
BibTeX
@article{Abdellatif2026,
author = {Abdellatif, Mohamed},
title = {Optimizing Anticoagulation in Atrial Fibrillation: The Role of Clinical Pharmacists in Canadian Practice},
journal = {International Journal of Clinical Pharmacy and Medicine},
year = {2026},
volume = {1},
number = {4},
doi = {10.68760/ijcpm.2026.01}
}
EUVIMED